Comprehensive Investigation Of Cannabis Science, A Recurrence Of Misleading Investors And Executive Self-Dealing
- Market Cap of $125M, Total Revenues of $200k, Total Expenses of $87M, Total Operating Deficit of $(90)M, Shareholder Deficit of $(2.96)M.
- Series of scattered and unprofitable business endeavors.
- History of illegal and deceptive activity among executives.
- Insolvency without continued dilution of shares.
- Misleading claims with regard to research and development of key flagship products.